BNP Paribas Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$383M Buy
1,521,377
+29,536
+2% +$6.35M 0.38% 42
2026
Q1
$324M Sell
1,491,841
-244,193
-14% -$54.2M 0.38% 46
2025
Q4
$397M Buy
1,736,034
+1,249,009
+256% +$285M 0.46% 36
2025
Q3
$112M Buy
487,025
+148,970
+44% +$30.3M 0.29% 65
2025
Q2
$62.8M Sell
338,055
-219,796
-39% -$40.8M 0.15% 139
2025
Q1
$117M Sell
557,851
-506,582
-48% -$98.5M 0.31% 73
2024
Q4
$189M Buy
1,064,433
+185,533
+21% +$34.1M 0.47% 37
2024
Q3
$174M Buy
878,900
+140,368
+19% +$26.2M 0.43% 45
2024
Q2
$127M Sell
738,532
-302,915
-29% -$50.2M 0.33% 61
2024
Q1
$190M Buy
1,041,447
+412,920
+66% +$71.2M 0.5% 42
2023
Q4
$97.4M Buy
628,527
+41,615
+7% +$6.07M 0.27% 90
2023
Q3
$87.5M Sell
586,912
-70,035
-11% -$10.3M 0.27% 93
2023
Q2
$88.5M Buy
656,947
+239,238
+57% +$35.1M 0.27% 91
2023
Q1
$66.6M Sell
417,709
-146,763
-26% -$22.4M 0.23% 107
2022
Q4
$91.2M Buy
564,472
+75,897
+16% +$11.6M 0.33% 72
2022
Q3
$65.6M Sell
488,575
-124,549
-20% -$17.9M 0.26% 88
2022
Q2
$93.9M Buy
613,124
+143,624
+31% +$21.9M 0.36% 60
2022
Q1
$76.1M Buy
469,500
+51,067
+12% +$7.42M 0.26% 82
2021
Q4
$56.7M Sell
418,433
-172,322
-29% -$20.4M 0.19% 128
2021
Q3
$63.7M Buy
590,755
+231,950
+65% +$26.5M 0.24% 98
2021
Q2
$40.4M Sell
358,805
-14,350
-4% -$1.62M 0.14% 176
2021
Q1
$40.4M Buy
373,155
+8,979
+2% +$960K 0.17% 149
2020
Q4
$39M Buy
364,176
+76,465
+27% +$7.35M 0.18% 140
2020
Q3
$25.2M Sell
287,711
-110,223
-28% -$10.4M 0.14% 178
2020
Q2
$39.1M Buy
397,934
+37,472
+10% +$3.3M 0.26% 100
2020
Q1
$27.5M Sell
360,462
-50,378
-12% -$4.29M 0.23% 125
2019
Q4
$36.4M Buy
410,840
+7,938
+2% +$659K 0.25% 117
2019
Q3
$30.5M Sell
402,902
-9,765
-2% -$669K 0.23% 117
2019
Q2
$30M Buy
412,667
+91,541
+29% +$7.2M 0.25% 109
2019
Q1
$25.9M Buy
321,126
+40,565
+14% +$3.32M 0.22% 125
2018
Q4
$25.6M Buy
280,561
+5,364
+2% +$472K 0.24% 113
2018
Q3
$26M Buy
275,197
+11,620
+4% +$1.1M 0.2% 135
2018
Q2
$24.4M Buy
263,577
+66,625
+34% +$6.51M 0.2% 130
2018
Q1
$18.6M Buy
196,952
+33,147
+20% +$3.64M 0.16% 170
2017
Q4
$15.8M Buy
163,805
+32,343
+25% +$3.05M 0.14% 213
2017
Q3
$11.7M Sell
131,462
-35,290
-21% -$2.69M 0.1% 283
2017
Q2
$12.1M Buy
166,752
+26,992
+19% +$1.81M 0.11% 259
2017
Q1
$9.11M Sell
139,760
-568,591
-80% -$35.7M 0.08% 331
2016
Q4
$44.4M Sell
708,351
-335,635
-32% -$20.5M 0.43% 52
2016
Q3
$65.8M Sell
1,043,986
-3,101
-0.3% -$201K 0.56% 30
2016
Q2
$64.8M Sell
1,047,087
-50,202
-5% -$3.06M 0.55% 31
2016
Q1
$62.7M Sell
1,097,289
-833,240
-43% -$46.4M 0.53% 31
2015
Q4
$114M Buy
1,930,529
+365,782
+23% +$21.1M 0.97% 6
2015
Q3
$85.1M Sell
1,564,747
-107,167
-6% -$6.98M 0.75% 13
2015
Q2
$112M Sell
1,671,914
-62,747
-4% -$4.1M 0.91% 6
2015
Q1
$102M Buy
1,734,661
+284,588
+20% +$17.2M 0.77% 12
2014
Q4
$94.9M Buy
1,450,073
+351,886
+32% +$22.2M 0.76% 12
2014
Q3
$63.4M Buy
1,098,187
+750,783
+216% +$41.7M 0.51% 38
2014
Q2
$19.6M Sell
347,404
-1,117
-0.3% -$58.6K 0.15% 182
2014
Q1
$17.9M Buy
348,521
+3,355
+1% +$170K 0.14% 187
2013
Q4
$18.2M Sell
345,166
-36,890
-10% -$1.81M 0.14% 191
2013
Q3
$17.1M Buy
382,056
+39,764
+12% +$1.76M 0.13% 207
2013
Q2
$14.2M Buy
+342,292
New +$15M 0.1% 230

Other funds holding ABBV

BNP Paribas Asset Management's ABBV Position: Q2 2026 in Review

BNP Paribas Asset Management increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $6.35M and bringing the position to 1,521,377 shares worth $383M. The position accounts for 0.38% of the portfolio, ranked #42.

BNP Paribas Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $397M in Q4 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BNP Paribas Asset Management held 1,521,377 shares of AbbVie worth $383M as of Q2 2026.
  • BNP Paribas Asset Management bought 29,536 AbbVie shares in Q2 2026, an estimated $6.35M.
  • AbbVie made up 0.38% of BNP Paribas Asset Management's portfolio in Q2 2026, its #42 holding.
  • BNP Paribas Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • BNP Paribas Asset Management's AbbVie position peaked at $397M in Q4 2025.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.